Poland· PL-100219971
Revolade
A eltrombopag product containing eltrombopagum, registered in Poland by Novartis Europharm Limited. The same ATC class is registered in 15 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Eltrombopag is registered in 15 of 19 countries.
Countries holding a registration under ATC B02BX05 (eltrombopag), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Eltrombopag · ATC B02BX05
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of eltrombopag costs, country by country.
Normalised to the WHO defined daily dose (50 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Eltrombopag · price per daily dose (50 mg)
USD · FX 28 Sept 2026
- CH Switzerland$38.37
The record
At a glance
URPL (Poland)- Active substance
- Eltrombopagum
- Manufacturer
- Novartis Europharm Limited
- Country
- Poland (PL)
- ATC code
- B02BX05
- ATC class
- Eltrombopag
- Defined daily dose
- 50 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05909990748198
- gtin05909990748204
- gtin05909990748211
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
175 interactions on record for eltrombopag.
Graded by severity as the source publishes them — 20 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Eltrombopag · interactions on record
175 records
- 20 severe
- 153 moderate
- 2 minor
Most severe, free to view
- EluxadolineA07DA06severe
- BerotralstatB06AC06severe
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Eltrombopag in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsEltrombopag Abdi 25 mg filmomhulde tablettenAbdi Farma GmbH
- SwitzerlandEltrombopag Accord
- SpainELTROMBOPAG ACCORD 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGAccord Healthcare S.L.U.
- SwedenEltrombopag Accord 25 mg Filmdragerad tablettAccord Healthcare S.L.U.
- NorwayEltrombopag AccordAccord Healthcare S.L.U.
- IrelandEltrombopag Krka 25 mg film-coated tabletsKRKA, d.d., Novo mesto
- United StatesELTROMBOPAGCamber Pharmaceuticals, Inc.
- United KingdomEltrombopag 25mg tabletsPerennial Pharma Ltd
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Elrevolan, Eltrombopag +pharma
- Belgium · Eltrombopag Krka
- Bulgaria · Eltrombopag Pharmascience, Eltrombopag Pharmdedict
- Cyprus · Eltrombopag Msn, Eltrombopag Sandoz
- Czechia · Eltrombopag Abdi, Eltrombopag Krka
- Germany · Eltrombopag 1 A Pharma, Eltrombopag Abdi
- Denmark · Eltrombopag Glenmark, Eltrombopag Krka
- Estonia · Eltrombopag Krka, Eltrombopag Msn
- Spain · Eltrombgopa Glenmark, Eltrombopag Aurovitas Spain
- Finland · Eltrombopag Avansor, Eltrombopag Krka
- France · Eltrombopag Biogaran, Eltrombopag Eg
- United Kingdom (Northern Ireland) · Eltrombopag Abdi, Eltrombopag Accord
- Greece · Eltrombopag Anabiosis, Eltrombopag Faran
- Croatia · Eltrombopag Alpha-Medical, Eltrombopag Msn
- Hungary · Elrevolan, Eltrombopag Elpen
- Ireland · Eltrombopag Clonmel, Eltrombopag Krka
- Iceland · Eltrombopag Accord, Eltrombopag Coripharma
- Italy · Elrevolan, Eltrombopag Abdi
- Liechtenstein · Eltrombopag Accord, Eltrombopag Viatris
- Lithuania · Eltrombopag Krka, Eltrombopag Msn
- Latvia · Eltrombopag Krka, Eltrombopag Olpha
- Malta · Eltrombopag Aspen, Eltrombopag Clonmel
- Netherlands · Eltrombopag Abdi, Eltrombopag Amarox
- Norway · Eltrombopag Accord, Eltrombopag Glenmark
- Portugal · Eltrombopag Bluepharma, Eltrombopag Cipla
- Romania · Eltrombopag Dr. Reddy’s, Eltrombopag Msn
- Sweden · Eltrombopag Anabiosis, Eltrombopag Avansor
- Slovenia · Eltrombopag Krka, Eltrombopag Msn
- Slovakia · Eltrombopag Glenmark, Eltrombopag Krka
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/df1e24c0-1a0b-4232-bb8d-936fae235b24 GET /v1/drugs/df1e24c0-1a0b-4232-bb8d-936fae235b24?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "25 mg",
"packaging": "05909990748198 ¦ Rpz ¦ EU/1/10/612/001 ¦ 54852\n14 tabl.\n05909990748204 ¦ Rpz ¦ EU/1/10/612/002 ¦ 54853\n28 tabl.\n05909990748211 ¦ Rpz ¦ EU/1/10/612/003 ¦ 54854\n84 tabl.",
"substance": "Eltrombopagum 25 mg",
"common_name": "Eltrombopagum",
"pl_product_id": "100219971",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about eltrombopag.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.